Search
Close this search box.
Follow us

Chronic lymphocytic leukemia (CLL)

chronic lymphocytic leukemia (CLL)

Quick review over chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia which is also called CLL is a cancer of the blood and bone marrow which usually is  worsen slowly; many patients don’t have any symptoms for at least the first few years, but over time, the cancer grows and spreads to other parts of the body, including the liver, spleen, and lymph […]

Small Lymphocytic Lymphoma SLL

Small Lymphocytic Lymphoma SLL

Small Lymphocytic Lymphoma (SLL) overview:   Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are cancers of the immune system; which affect lymphocytes. CLL and SLL are basically the same, the only difference is each cancer is primarily located in a different part of the body. When cancer occurs in bloodstream and the bone […]

Mantle cell lymphoma (MCL)

Mantle cell lymphoma (MCL)

Quick overview of Mantle cell lymphoma (MCL)   Mantle cell lymphoma (MCL) is grouped as one of the rare B-cell non-Hodgkin lymphoma (NHL). In non-Hodgkin lymphoma cancer, the lymphatic system is affected. About 6 to 8 percent of all NHLs are Mantle cell lymphoma (MCL). This type of cancer is called “mantle cell lymphoma”, because […]

Marginal Zone Lymphoma (MZL)

Marginal Zone Lymphoma (MZL)

Quick overview of Marginal Zone Lymphoma (MZL): Marginal zone lymphoma (MZL) which is also called marginal zone B-cell lymphoma, is a group of B-cell non-Hodgkin lymphomas, which at first is formed in certain areas (the marginal zones) of lymph tissue. MZL is the second most common indolent non-Hodgkin’s lymphoma (iNHL); and account for approximately eight […]

Waldenstrom Macroglobulinemia (WM)

Waldenstrom Macroglobulinemia (WM)

Introduction of Waldenstrom Macroglobulinemia (WM)   Waldenstrom Macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL), in which the cancer cells make large amounts of an abnormal protein (called a macroglobulin). Another name for this subtype of NHL cancers is lymphoplasmacytic lymphoma. This condition is a rare indolent B-cell lymphoma that occurs in less than two percent of […]

Graft-versus-Host Disease (GvHD)

Graft-versus-Host Disease (GvHD)

Quick Review over Graft-versus-Host Disease (GvHD) Introduction: Graft-versus-Host Disease (GvHD) is a common complication because of a transplantation using donor; this complication occurs when the donor’s immune system (the graft) recognizes the patient’s organs and tissues (the host) as unfamiliar cells that should be destroyed. This complication is triggered by a type of white blood cell […]

Cancer Statistics

Cancer

Cancer statistics According to the American Cancer Society’s annual estimate of 2021, there will be 1898160 new cases and 608570 deaths caused by that in the United States. In generally, due to improvements in various facets of humans’ lives, including availability of different instruments for diagnosing mortality rate has shrunk from its peak in 1991 […]

Multiple sclerosis (MS)

Multiple sclerosis (MS)

Quick Review over Multiple sclerosis (MS)   Multiple sclerosis (MS) is a lifelong, and often disabling disease which affects the central nervous system (brain and spine). In multiple sclerosis, scattered patches of the protective myelin covering of the nerve fibers in the CNS are damaged or destroyed. This leads to inflammation and loss of myelin which […]

Protein Tyrosine Kinases:Their Roles and Their Targeting in Leukemia

Protein Tyrosine Kinases

Protein tyrosine kinases superfamily definition A large group of enzymes that speeding up protein phosphorylation and controlling multiple signaling incidents are titled as Protein tyrosine kinases, which represents a complicated system and is wrapped up by of 518 members. Based on their ability to phosphorylate either tyrosine or serine and threonine residues, they are classified into two main […]

Disease modifying therapies (DMTs)

Quick Review Over Disease Modifying Therapies (DMTs) For Multiple Sclerosis Introduction: Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the CNS. Although there is no curable options for MS, a number of medications also called, disease modifying therapies, or DMTs, have been approved to treat MS. Permanent damage to the central nervous system can […]